PATH [to 14 January 2017]

PATH [to 14 January 2017]

Announcement | January 12, 2017
PATH welcomes grant to advance Group B Streptococcus vaccine development
Award from the Bill & Melinda Gates Foundation will support maternal immunization strategies
PATH has received a five-year, $29.3 million grant from the Bill & Melinda Gates Foundation to support the development of a vaccine against Group B Streptococcus (GBS), a leading cause of sepsis and meningitis in young infants worldwide. A vaccine to prevent the bacterial infection—which often affects babies just a few hours old—could potentially save countless lives in the low-resource countries most impacted by the disease. Grant funds will support the research and development of a polyvalent, conjugate vaccine protecting against the most common kinds (or serotypes) of GBS…